Khan Muhammad Ahmad, Khan Saif Ur Rehman, Lin Ding
Group Co, Aier Eye Hospital, South Furong Rd, Ltd, ChangshaHunan, China.
School of Computer Science and Engineering, Central South University, Yuelu District, 932 Lushan S Rd, ChangshaHunan, China.
BMC Ophthalmol. 2025 May 22;25(1):303. doi: 10.1186/s12886-025-04135-3.
High myopia correction is essential for improving visual acuity and quality of life. Traditional intraocular collamer lens (ICL) implantation using an ophthalmic viscosurgical device (OVD) is effective but often results in prolonged surgical times, impacting patient comfort and recovery. This study investigates a novel non-OVD ICL implantation technique aimed at reducing surgical duration and improving patient outcomes.
This prospective, randomized controlled trial was conducted at Changsha Aier Eye Hospital from May to August 2024, enrolling 162 right eyes from high myopic patients aged 21 to 45 years. Participants were randomly assigned to either the non-OVD group, which utilized a disposable sterile irrigator for anterior chamber maintenance, or the OVD group, which underwent traditional ICL implantation. Primary outcomes included surgical time, endothelial cell density (ECD), intraocular pressure (IOP), and patient-reported experiences.
The non-OVD group demonstrated a significant reduction in surgical time (113 ± 103 s) compared to the OVD group (436 ± 118 s, p < 0.001). ECD and IOP remained stable postoperatively, indicating no adverse effects on ocular health. Patient experiences were assessed through pain levels and self-perception reports; the non-OVD group reported comparable pain levels with enhanced self-perception compared to the OVD group.
The novel non-OVD ICL implantation technique significantly reduces surgical duration while maintaining ocular health and improving patient self-perception. Additional to it, we also explored patients' self-perception, which refers to their subjective evaluation of recovery, well-being, and visual outcomes post-surgery. Unlike satisfaction, which primarily measures how pleased patients are with the results, self-perception encompasses how patients feel about their overall recovery process, including psychological and emotional factors. This approach may enhance operational efficiency and patient comfort in high myopia surgeries.
The study was registered with the China Clinical Trial Registration Center (Registration No. ChiCTR2100046483, Trial Registration: 2021-03-06).
高度近视矫正对于提高视力和生活质量至关重要。使用眼科粘弹剂(OVD)的传统人工晶状体植入术(ICL)是有效的,但手术时间往往较长,影响患者舒适度和恢复。本研究调查了一种新型非OVD ICL植入技术,旨在缩短手术时间并改善患者预后。
本前瞻性随机对照试验于2024年5月至8月在长沙爱尔眼科医院进行,纳入162例年龄在21至45岁的高度近视患者的右眼。参与者被随机分配到非OVD组,该组使用一次性无菌冲洗器维持前房,或OVD组,该组接受传统ICL植入术。主要结局包括手术时间、内皮细胞密度(ECD)、眼压(IOP)以及患者报告的体验。
与OVD组(436±118秒)相比,非OVD组的手术时间显著缩短(113±103秒,p<0.001)。术后ECD和IOP保持稳定,表明对眼部健康无不良影响。通过疼痛程度和自我感知报告评估患者体验;与OVD组相比,非OVD组报告的疼痛程度相当,但自我感知增强。
新型非OVD ICL植入技术在保持眼部健康和改善患者自我感知的同时,显著缩短了手术时间。此外,我们还探讨了患者的自我感知,这是指他们对术后恢复、健康状况和视觉效果的主观评价。与主要衡量患者对结果满意程度的满意度不同,自我感知涵盖了患者对整个恢复过程的感受,包括心理和情感因素。这种方法可能会提高高度近视手术的操作效率和患者舒适度。
该研究已在中国临床试验注册中心注册(注册号:ChiCTR2100046483,试验注册时间:2021年3月6日)。